Notable Downgrades: TriVascular Technologies (TRIV), Zumiez (ZUMZ), Alcoa Inc. (AA)

TriVascular Technologies, Inc. (TRIV) was reiterated a ‘Buy’ by Canaccord Genuity analysts on Thursday. The broker also cut its price target on the stock to $13 from $19.

TRIV shares recently lost $1.08 to $8.99. The stock is down 34.81 year-over-year and has lost roughly 20% year-to-date. In the past 52 weeks, shares of Santa Rosa, California-based medical device company have traded between a low of $8.00 and a high of $17.99.

TriVascular Technologies, Inc. closed Wednesday at $10.07. The name has a total market cap of $173.77 million.

Zumiez, Inc. (ZUMZ) was reiterated as ‘Buy’ with a $42 from $45 price target on Thursday by ROTH Capital.

On valuation measures, Zumiez, Inc. shares are currently priced at 24.07x this year’s forecasted earnings compared to the industry’s 19.26x earnings multiple. Ticker has a PEG and forward P/E ratio of 1.43 and 16.44, respectively. Price/Sales for the same period is 1.37 while EPS is $1.47. Currently there are 5 analysts that rate ZUMZ a ‘Buy’, 14 rate it a ‘Hold’. No analyst rates it a ‘Sell’. ZUMZ has a median Wall Street price target of $40.00 with a high target of $48.00.

In the past 52 weeks, shares of Lynnwood, Washington-based company have traded between a low of $23.50 and a high of $41.81 and are now at $35.39. Shares are up 55.52% year-over-year ; down 1.89% year-to-date.

Alcoa Inc. (AA) rating of ‘Buy’ was reiterated today at Stifel with a price target decrease of $19 from $20 (versus a $13.67 previous close).

On Thursday, Alcoa Inc. printed a higher than average trading volume with the issue trading 44.33 million shares, compared to the average volume of 24.59 million. The stock began trading this morning at $13.42 to currently trade 4.13% lower from the prior days close of $13.67. On an intraday basis it has gotten as low as $12.96 and as high as $13.45.

Alcoa shares are currently priced at 62.38x this year’s forecasted earnings, compared to the industry’s 55.43x earnings multiple. The company’s current year and next year EPS growth estimates stand at 15.20% and 18.90% compared to the industry growth rates of 24.70% and 79.80%, respectively. AA has a t-12 price/sales ratio of 0.70. EPS for the same period registers at $0.21.

AA’s shares have declined 0.22% in the last 4 weeks and 9.11% in the past three months. Over the past 5 trading sessions the stock has gained 5.80%.

The New York-based aluminum giant, which is currently valued at $16.01 billion, has a median Wall Street price target of $18.00 with a high target of $23.00. AA is up 10.51% year-over-year ; down down 13.26%  year-to-date.

Disclaimer: This page contains affiliate links. If you choose to make a purchase after clicking a link, we may receive a commission at no additional cost to you. Thank you for your support!

Be the first to comment

Leave a Reply

Your email address will not be published.


This site uses Akismet to reduce spam. Learn how your comment data is processed.